Dynavax Technologies Corporation (DVAX)
NASDAQ: DVAX · Real-Time Price · USD
10.25
+0.29 (2.96%)
At close: Jun 6, 2025, 4:00 PM
9.82
-0.42 (-4.15%)
After-hours: Jun 6, 2025, 7:09 PM EDT

Dynavax Technologies Market Cap

Dynavax Technologies has a market cap or net worth of $1.23 billion as of June 6, 2025. Its market cap has decreased by -18.02% in one year.

Market Cap
1.23B
Enterprise Value
858.40M
1-Year Change
-18.02%
Ranking
Category
Stock Price
$10.25

Market Cap Chart

Since February 19, 2004, Dynavax Technologies's market cap has increased from $222.50M to $1.23B, an increase of 452.64%. That is a compound annual growth rate of 8.35%.

History

DateMarket Cap% Change
Jun 6, 20251.23B-26.75%
Dec 31, 20241.68B-7.11%
Dec 29, 20231.81B33.12%
Dec 30, 20221.36B-19.57%
Dec 31, 20211.69B244.22%
Dec 31, 2020490.30M2.21%
Dec 31, 2019479.70M-16.37%
Dec 31, 2018573.60M-49.38%
Dec 29, 20171.13B644.48%
Dec 30, 2016152.20M-83.61%
Dec 31, 2015928.40M109.43%
Dec 31, 2014443.30M-13.87%
Dec 31, 2013514.70M1.06%
Dec 31, 2012509.30M20.97%
Dec 30, 2011421.00M13.85%
Dec 31, 2010369.80M531.06%
Dec 31, 200958.60M74.93%
Dec 31, 200833.50M-83.51%
Dec 31, 2007203.20M-41.66%
Dec 29, 2006348.30M177.97%
Dec 30, 2005125.30M-36.40%
Dec 31, 2004197.00M-11.46%
View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 691.15B
Johnson & Johnson 373.01B
AbbVie 335.32B
Novo Nordisk 332.47B
UnitedHealth Group 275.06B
Abbott Laboratories 232.41B
Novartis AG 231.17B
AstraZeneca 226.14B
Market Cap Rankings